39 results on '"Mariette , Xavier"'
Search Results
2. Characterisation of airway disease associated with Sjögren disease
3. Comparison between primary Sjögren’s disease patients with high or low level of dryness
4. Efficacy of daratumumab in refractory primary Sjögren disease
5. Impact of patient ancestry on heterogeneity of Sjögren’s disease
6. Interferon signature in systemic autoimmune diseases: what does it mean?
7. Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)
8. Machine learning predicts response to TNF inhibitors in rheumatoid arthritis: results on the ESPOIR and ABIRISK cohorts
9. SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry
10. Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare database
11. Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses
12. Passive smoking in childhood and adulthood and risk of rheumatoid arthritis in women: results from the French E3N cohort study
13. Characteristics of Sjögren’s syndrome associated with rheumatoid arthritis
14. Articular manifestations in patients with inflammatory bowel diseases treated with anti-TNF
15. Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to consider
16. Lymphoma complicating rheumatoid arthritis: results from a French case–control study
17. Association between T follicular helper cells and T peripheral helper cells with B-cell biomarkers and disease activity in primary Sjögren syndrome
18. Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to consider
19. Normal salivary gland ultrasonography could rule out the diagnosis of Sjögren’s syndrome in anti-SSA-negative patients with sicca syndrome
20. Efficacy and safety of rituximab in peripheral ulcerative keratitis associated with rheumatoid arthritis
21. Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme
22. Passive smoking in childhood and adulthood and risk of rheumatoid arthritis in women: results from the French E3N cohort study.
23. Large granular lymphocyte expansions in primary Sjögren’s syndrome: characteristics and outcomes
24. Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren’s syndrome
25. Anti-RNP positivity in primary Sjögren’s syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement
26. Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients
27. Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn’s disease: a pooled analysis of 11 317 patients across clinical trials
28. Sjögren’s syndrome: state of the art on clinical practice guidelines
29. Real-world predictors of 12–month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational study
30. Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the ‘ORA’ registry
31. Variants of genes implicated in type 1 interferon pathway and B-cell activation modulate the EULAR response to rituximab at 24 weeks in rheumatoid arthritis
32. Sustainability of TNF-blocker tapering in rheumatoid arthritis over 3 years: long-term follow-up of the STRASS (Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study) randomised controlled trial
33. Baseline autoantibodies preferentially impact abatacept efficacy in patients with rheumatoid arthritis who are biologic naïve: 6-month results from a real-world, international, prospective study
34. Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort
35. Predictive value of tender joints compared to synovitis for structural damage in rheumatoid arthritis
36. Cardiovascular and selected comorbidities in early arthritis and early spondyloarthritis, a comparative study: results from the ESPOIR and DESIR cohorts
37. EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.
38. Stability of symptom-based subtypes in Sjogren's disease.
39. Development of a web-based ecological momentary assessment tool to measure day-to-day variability of the symptoms in patients with Sjögren's disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.